Ignite Creation Date:
2024-05-06 @ 10:58 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03392909
Status:
RECRUITING
Last Update Posted:
2022-11-03
First Post:
2018-01-02
Brief Title:
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa RDEB
Sponsor:
University of Southern California
Organization:
University of Southern California
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-02
First Submit QC Date:
January 2 2018
Study First Post Date:
2018-01-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-01
Last Update Post Date:
2022-11-03
Last Update Post Date Type:
ACTUAL